Fresh Equities



COCHLEAR LIMITED has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise
$500k - $1m
Investors Interested in Next Raise
10 - 25
How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.


2. View Terms

View the full term sheet for the capital raise.


3. Bid for Allocation

Submit and track your bid online.

Capital Raise History


Company Overview

Cochlear Limited (COH) is a manufacturer and distributor of cochlear implantable devices for hearing impaired. Cochlear have operations in more than 20 countries distributing its products in America, Asia Pacific, Europe, Middle East and Africa. It offers three main products namely: Cochlear implants, Baha bone conduction implants and Cochlear Wireless Accessories.


Listed Company

GICS Sub-industry

Health Care Equipment

Head Office

Balaclava Rd, North Ryde NSW 2109, Australia

Health Care Equipment
Health Care
Biotech & Health

Price Chart

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.



Fresh Equities does not have COCHLEAR LIMITED directors data.


All Time
    Appendix 3B - Update to Proposed Issue of Securities - COH on 27 March 2020

    Issued Capital

  • Successful completion of A$880M Institutional Placement on 25 March 2020

    Issued Capital

  • Proposed issue of Securities - COH on 24 March 2020

    Issued Capital

  • Investor Presentation on 24 March 2020

    Periodic Reports

  • Cochlear Limited announces capital raising to enhance liquid on 24 March 2020

    Periodic Reports

  • Trading Halt on 24 March 2020

    Stock Exchange Announcement

  • Adverse appeal decision in the US patent infringement case on 16 March 2020

    Progress Report

  • Cochlear withdraws FY20 earnings guidance due to coronavirus on 15 March 2020

    Progress Report

  • Appendix 2A on 12 March 2020

    Issued Capital

  • HY20 Result Presentation Slides on 17 February 2020

    Periodic Reports

  • Load More